Position in NKTR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,579,479
-$9,344,368 QoQ
Shares Held
35,851
-87.3% QoQ
Ownership
0.105%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Derivatives in NKTR
reported options exposure · as of Sep 30, 2025CallValue
$557,620
CallShares
9,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in NKTR
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,579,479 | 35,851 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,923,847 | 282,021 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,402,116 | 182,814 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $557,620 | 9,800 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $9,981,733 | 386,290 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $578,078 | 850,115 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $390,457 | 300,352 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $327,438 | 264,063 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $278,658 | 299,633 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $616,000 | 1,100,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $800,200 | 1,333,668 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,792 | 44,470 | Shares | Sole | 2023-08-14 | |
| 2022-09-30 | $46,438 | 14,512 | Shares | Other | 2022-11-15 | |
| 2022-03-31 | $3,604,977 | 668,827 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $411,784 | 30,480 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,116,383 | 173,518 | Shares | Sole | 2021-12-01 | |
| No filing history on record for this holder in this stock. | ||||||